SPOTLIGHT -
EP. 1: Global Trends in Gastroesophageal Cancer
EP. 2: Gastroesophageal Cancer: Initial Approaches
EP. 3: Next-Generation Sequencing for Gastric and GEJ Cancer
EP. 4: FLOT Regimen for Resectable Gastroesophageal Cancer
EP. 5: Improving Surgical Outcomes for Gastroesophageal Cancer
EP. 6: Guidelines for Metastatic Frontline Therapy in GEC
EP. 7: Second-line Treatment for Recurrent or Progressive GEC
EP. 8: RAINBOW Study: Antiangiogenic Therapy in Gastric Cancer
EP. 9: PD-1 Inhibitors for Advanced Gastroesophageal Cancer
EP. 10: Shortfalls in Recent Gastroesophageal Clinical Trials
EP. 11: Checkpoint Inhibitors: Emerging Role in GE Cancer
EP. 12: Novel Targeted Approaches in Gastroesophageal Cancer
EP. 13: Evolving Global Treatment Landscape for Gastric Cancer
Up-Front Osimertinib Provides Comparable OS, Improved Brain PFS Vs Sequential Gefitinib/Osimertinib in EGFR+ NSCLC
Dr Nasioudis on the Use of NGS to Identify the Molecular Profile of Endometroid Ovarian Cancer
Dr Buckingham on the Use of Patient-reported Outcomes to Predict Frailty in Patients With Ovarian Cancer
Dr Slomovitz on the Investigation of Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Carcinoma
